Health-care companies fell sharply amid regulatory concerns. AstraZeneca plans a new investment of $2 billion in the U.S., one of the first major foreign companies to shift spending to the country ...

Welcome to the Regulatory Roundup. Each month, Eversheds Sutherland Investment Services attorneys review significant regulatory developments (including notable rulemakings and guidance from securities ...

A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers ...

Trump has pledged to reverse many actions of the Biden administration using executive orders, the Congressional Review Act, ...

Bitcoin hit another high Monday, as the rally in cryptocurrencies continued following President-elect Donald Trump's election ...